Quest Diagnostics Inc Interest Rate Fair Value Hedge Asset at Fair Value
Quest Diagnostics Inc (DGX) had Interest Rate Fair Value Hedge Asset at Fair Value of $3.00 million as of 2026-03-31, per its 10-Q filed 2026-04-22.
Financial Statements › Notes › Interest Rate Fair Value Hedge Derivative at Fair Value, Net
us-gaap:InterestRateFairValueHedgeAssetAtFairValue · last filed 2026-07-23
- 2026-03-31: Interest Rate Fair Value Hedge Asset at Fair Value $3.00M.
- 2025-12-31: Interest Rate Fair Value Hedge Asset at Fair Value $14.00M.
| Period end | Interest Rate Fair Value Hedge Asset at Fair Value |
|---|---|
| 2026-03-31 | $3.00M 10-Q · filed 2026-04-22 |
| 2025-12-31 | $14.00M 10-Q · filed 2026-07-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LABCORP HOLDINGS INC. (LH) | United States | $25.060B | 22.60 |
| Guardant Health, Inc. (GH) | United States | $23.675B | -12.65 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |